ARCHIVES

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

This article is from The Cancer Letter archive.

Vol. 15 No. 23 | June 9, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Adds $25 Million to R01, P01 Grant Pool In Fiscal 1990

February 23, 1990

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

October 11, 1996

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997